On December 14, 2023, Hasten Biopharmaceutical Co., Ltd. announced that it will enter into a strategic business partnership with Apeloa Pharmaceutical Co., Ltd.
Summer XIA Shaofei, CEO of Hasten, said, “We are very pleased to form a strategic business partnership with Apeloa. Apeloa has outstanding pharmaceutical manufacture facilities, R&D capabilities, and quality control systems, which provide a good collaboration platform for the development of global innovative pharmaceutical companies. This cooperation will better help Hasten realize its corporate mission of 'providing high-quality medicines and solutions that improve lives of people and create social value’."
We are proud to announce that Apeloa has received the "API Development & Innovation Award" and the "Premium Global Partner" award at CPHI China 2024!
Next：Innovation Milestone: Apeloa Pharmaceutical CDMO Global Service Platform Ready for Use, Pharmaceutical Manufacturing Innovation Forum Held
